NovaBay Pharmaceuticals reported preliminary revenue results for the second quarter and first half of 2024. For the second quarter, the company reported net revenue of $2.4 million.

For the first half of 2024, the company reported net revenue of $5.0 million, primarily derived from the Company?s eyecare products.